TrialRMD open2026

Treat-to-target strategies are feasible in elderly-onset rheumatoid arthritis given its reassuring risk-benefit profile.

Hamit Harun Dag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.